HealthCare Global Enterprises organizacji Cena/Sprzedaż
Jaka jest wartość Cena/Sprzedaż organizacji HealthCare Global Enterprises?
Wartość Cena/Sprzedaż organizacji HealthCare Global Enterprises Limited to 2.76
Jaka jest definicja Cena/Sprzedaż?
Wskaźnik ceny do zysku (Price to sales ratio) to wskaźnik reprezentuje koszt firmy w porównaniu do kwoty jej sprzedaży.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Cena/Sprzedaż firm w Health Care sektor na NSE w porównaniu do HealthCare Global Enterprises
Czym się zajmuję organizacja HealthCare Global Enterprises?
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2022, the company operated 22 comprehensive cancer centers, including 1 center in Africa. The company was founded in 1989 and is based in Bengaluru, India.
Firmy z cena/sprzedaż podobne do HealthCare Global Enterprises
- Wartość Cena/Sprzedaż organizacji Castrol India to 2.76
- Wartość Cena/Sprzedaż organizacji Marriott International to 2.76
- Wartość Cena/Sprzedaż organizacji Zynex Inc to 2.76
- Wartość Cena/Sprzedaż organizacji Recon Technology Ltd to 2.76
- Wartość Cena/Sprzedaż organizacji Riskified to 2.76
- Wartość Cena/Sprzedaż organizacji Tortoise Midstream Fund Inc to 2.76
- Wartość Cena/Sprzedaż organizacji HealthCare Global Enterprises to 2.76
- Wartość Cena/Sprzedaż organizacji The Karur Vysya Bank to 2.76
- Wartość Cena/Sprzedaż organizacji CSPC Pharmaceutical to 2.76
- Wartość Cena/Sprzedaż organizacji Cohen & Steers Quality Income Realty Fund to 2.76
- Wartość Cena/Sprzedaż organizacji WEX Inc to 2.76
- Wartość Cena/Sprzedaż organizacji Santos to 2.76
- Wartość Cena/Sprzedaż organizacji Beam Global to 2.76